Molecule of the month: miRNA and Multiple Sclerosis.
作者信息
Shapshak Paul
机构信息
Divsion of Infectious Disease and International Health, Department of Medicine and Department of Psychiatry and Behavioral Medicine, USF Morsani School of Medicine, Tampa General Hospital, 1 Tampa Gen Circle, Room G318, Tampa FL 33606 ; Divsion of Infectious Disease and International Health, Department of Medicine and Department of Psychiatry and Behavioral Medicine, USF Morsani School of Medicine, Tampa General Hospital, 1 Tampa Gen Circle, Room G318, Tampa FL 33606.
出版信息
Bioinformation. 2013 Oct 16;9(17):847-8. doi: 10.6026/97320630009847. eCollection 2013.
Abstract
摘要
相似文献
1
Molecule of the month: miRNA and Multiple Sclerosis.本月分子：微小RNA与多发性硬化症。
Bioinformation. 2013 Oct 16;9(17):847-8. doi: 10.6026/97320630009847. eCollection 2013.
2
Serum Based miRNA as a Diagnostic Biomarker for Multiple Sclerosis: a Systematic Review and Meta-Analysis.基于血清的 miRNA 作为多发性硬化症的诊断生物标志物：系统评价和荟萃分析。
Immunol Invest. 2022 May;51(4):947-962. doi: 10.1080/08820139.2021.1887888. Epub 2021 Mar 4.
3
Association between miRNA-145 and miRNA-155 expression in peripheral blood mononuclear cells of patients with multiple sclerosis: a case-control study.多发性硬化症患者外周血单个核细胞中 miRNA-145 和 miRNA-155 表达的相关性：一项病例对照研究。
BMC Neurol. 2022 Nov 3;22(1):405. doi: 10.1186/s12883-022-02909-6.
4
MicroRNA-22 Level in Patients with Multiple Sclerosis and Its Relationship with Vitamin D and Vitamin D Receptor Levels.多发性硬化症患者的 microRNA-22 水平及其与维生素 D 和维生素 D 受体水平的关系。
Neuroimmunomodulation. 2022;29(2):128-134. doi: 10.1159/000519012. Epub 2021 Sep 17.
5
Deregulation of microRNA-181c in cerebrospinal fluid of patients with clinically isolated syndrome is associated with early conversion to relapsing-remitting multiple sclerosis.临床孤立综合征患者脑脊液中微小RNA-181c的失调与早期转化为复发缓解型多发性硬化症有关。
Mult Scler. 2016 Aug;22(9):1202-14. doi: 10.1177/1352458515613641. Epub 2015 Oct 22.
6
MiRNA 106a-5p in cerebrospinal fluid as signature of early relapsing remitting multiple sclerosis: a cross sectional study.脑脊液中 miRNA106a-5p 作为早期复发缓解型多发性硬化症的特征：一项横断面研究。
Front Immunol. 2023 Aug 30;14:1226130. doi: 10.3389/fimmu.2023.1226130. eCollection 2023.
7
Early miR-320b and miR-25-3p miRNA levels correlate with multiple sclerosis severity at 10 years: a cohort study.早期 miR-320b 和 miR-25-3p 微 RNA 水平与 10 年后多发性硬化症严重程度相关：一项队列研究。
J Neuroinflammation. 2023 Jun 1;20(1):136. doi: 10.1186/s12974-023-02816-8.
8
miRNA 548a-3p as biomarker of NEDA-3 at 2 years in multiple sclerosis patients treated with fingolimod.在接受芬戈莫德治疗的多发性硬化症患者中，miRNA 548a-3p 可作为 2 年内无疾病活动度、残疾进展和影像学加重（NEDA-3）的生物标志物。
J Neuroinflammation. 2023 May 30;20(1):131. doi: 10.1186/s12974-023-02811-z.
9
Plasmatic microRNA as Potential Biomarkers of Multiple Sclerosis: Literature Review.血浆 microRNA 作为多发性硬化症的潜在生物标志物：文献综述。
Adv Clin Exp Med. 2016 Jul-Aug;25(4):775-9. doi: 10.17219/acem/60098.
10
Blood miRNA expression pattern is a possible risk marker for natalizumab-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients.血液 microRNA 表达模式可能是多发性硬化症患者接受那他珠单抗治疗后发生进行性多灶性白质脑病的风险标志物。
Mult Scler. 2014 Dec;20(14):1851-9. doi: 10.1177/1352458514534513. Epub 2014 May 22.
引用本文的文献
1
Predict MiRNA-Disease Association with Collaborative Filtering.基于协同过滤的 miRNA-疾病关联预测
Neuroinformatics. 2018 Oct;16(3-4):363-372. doi: 10.1007/s12021-018-9386-9.
2
Expression, regulation and function of microRNAs in multiple sclerosis.微小RNA在多发性硬化症中的表达、调控及功能
Int J Med Sci. 2014 Jun 2;11(8):810-8. doi: 10.7150/ijms.8647. eCollection 2014.
本文引用的文献
1
A polymorphism in the resistin gene promoter and the risk of multiple sclerosis.抵抗素基因启动子多态性与多发性硬化症的风险。
Minerva Med. 2013 Aug;104(4):431-8.
2
Autoantigens and autoantibodies in multiple sclerosis.多发性硬化症中的自身抗原与自身抗体
Iran J Allergy Asthma Immunol. 2013 Aug 28;12(4):292-303.
3
Multiple sclerosis is primarily a neurodegenerative disease.多发性硬化症主要是一种神经退行性疾病。
J Neural Transm (Vienna). 2013 Oct;120(10):1463-6. doi: 10.1007/s00702-013-1080-3. Epub 2013 Aug 28.
4
miR-155 as a multiple sclerosis-relevant regulator of myeloid cell polarization.miR-155 作为调节髓系细胞极化的多发性硬化症相关调控因子。
Ann Neurol. 2013 Nov;74(5):709-20. doi: 10.1002/ana.23967. Epub 2013 Sep 23.
5
Noncoding RNAs in Neurodegenerative Diseases.神经退行性疾病中的非编码RNA
ISRN Neurol. 2013 Apr 30;2013:375852. doi: 10.1155/2013/375852. Print 2013.
6
MicroRNAs regulate human brain endothelial cell-barrier function in inflammation: implications for multiple sclerosis.微小 RNA 调控人类脑内皮细胞在炎症中的屏障功能：对多发性硬化症的影响。
J Neurosci. 2013 Apr 17;33(16):6857-63. doi: 10.1523/JNEUROSCI.3965-12.2013.
7
Hippocampal demyelination and memory dysfunction are associated with increased levels of the neuronal microRNA miR-124 and reduced AMPA receptors.海马脱髓鞘和记忆功能障碍与神经元 microRNA miR-124 水平升高和 AMPA 受体减少有关。
Ann Neurol. 2013 May;73(5):637-45. doi: 10.1002/ana.23860. Epub 2013 Apr 17.
8
Jean-martin charcot pathologist, neurologist, psychiatrist and physician.让-马丁·沙可，病理学家、神经学家、精神科医生及内科医生。
Ann Indian Acad Neurol. 2012 Oct;15(4):297-8. doi: 10.4103/0972-2327.104340.
9
MicroRNAs as active players in the pathogenesis of multiple sclerosis.微小RNA在多发性硬化症发病机制中作为活跃参与者。
Int J Mol Sci. 2012 Oct 15;13(10):13227-39. doi: 10.3390/ijms131013227.
10
Integration of MicroRNA databases to study MicroRNAs associated with multiple sclerosis.整合 MicroRNA 数据库以研究与多发性硬化症相关的 MicroRNAs。
Mol Neurobiol. 2012 Jun;45(3):520-35. doi: 10.1007/s12035-012-8270-0. Epub 2012 May 2.
Zotero 插件